DOSSIER · UPDATED 18 NOV 2025

Myrobalan Therapeutics

Myro Therapeutics is a biotechnology company that focuses on the development of therapeutic solutions for Central Nervous System (CNS) disorders. The company's approach is rooted in a deep understanding of disease biology and mechanisms,…

myrotx.com ↗Claim this profile

Founded: 2021
Headcount: 11
Open roles: 0
Last raised: Grant · $850K

SECTION I · THE BRIEF

Inside Myrobalan Therapeutics

Brief #38031Updated 18 NOV 2025MEDFORDSOFTWARE COMPANIESGRANT

Employbl Dossier

Myrobalan Therapeutics

Founded: 2021
Headcount: 11
Open roles: 0
Last raised: Grant · $850K

Section II — RestrictedMembers only

Engineering interview process at Myrobalan Therapeutics
Tech stack & infrastructure choices
Culture & day-to-day work style
Why join now vs. 6 months from now
Hiring focus & open headcount by team
Comp philosophy and band context

Open Myrobalan Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Guoping Feng

Jing Wang

Zhigang He

OPEN ROLES

Hiring at Myrobalan Therapeutics

Current Job Listings

Listing 0 of 0 job openings

We don't currently have any jobs listed for this company. We suggest visiting the Jobs Search page if you are looking for exciting new tech and startup opportunities.

FUNDING

Capital raised

Total Amount Raised: $34,250,000

Myrobalan Therapeutics Funding Rounds

Grant
$850,000
Mar 13, 2025
Grant
$850,000
Mar 12, 2025
Grant Investors
National Multiple Sclerosis Society
Series A
$9,000,000
Jul 29, 2024
Series A
$9,000,000
Jul 28, 2024
Grant
$400,000
Feb 7, 2024
Grant
$400,000
Feb 6, 2024
Grant Investors
The ALS Association Florida Chapter
Series A
$24,000,000
Jan 10, 2024
Series A
$24,000,000
Jan 9, 2024
Series A Investors
Cowin Venture
AB Magnitude Ventures Group
3E Bioventures Capital
Guanzi Capital